Hsbc Holdings PLC Has $174.97 Million Stock Position in Cencora, Inc. $COR

Hsbc Holdings PLC lifted its position in shares of Cencora, Inc. (NYSE:COR) by 41.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 557,491 shares of the company’s stock after acquiring an additional 163,533 shares during the quarter. Hsbc Holdings PLC’s holdings in Cencora were worth $174,971,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Kemnay Advisory Services Inc. bought a new position in Cencora in the fourth quarter valued at about $25,000. Oakworth Capital Inc. bought a new stake in Cencora during the 4th quarter worth about $26,000. Elyxium Wealth LLC acquired a new position in Cencora during the 4th quarter valued at about $27,000. Archer Investment Corp lifted its position in Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Finally, Motiv8 Investments LLC bought a new position in shares of Cencora in the 4th quarter valued at about $29,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Transactions at Cencora

In other Cencora news, Director Lauren M. Tyler bought 550 shares of the stock in a transaction that occurred on Monday, June 22nd. The stock was acquired at an average cost of $270.23 per share, with a total value of $148,626.50. Following the purchase, the director owned 4,359 shares in the company, valued at $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.38% of the company’s stock.

Cencora Stock Performance

COR stock opened at $307.72 on Friday. The business’s 50-day moving average price is $279.98 and its two-hundred day moving average price is $317.68. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The firm has a market cap of $59.87 billion, a PE ratio of 23.60, a P/E/G ratio of 1.71 and a beta of 0.58. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The business had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm’s revenue was up 3.9% compared to the same quarter last year. During the same quarter last year, the company earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, research analysts forecast that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora announced that its Board of Directors has initiated a stock buyback program on Thursday, May 21st that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to buy up to 3.9% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its shares are undervalued.

Cencora Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were given a $0.60 dividend. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. Cencora’s payout ratio is currently 18.40%.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Evercore set a $360.00 price target on shares of Cencora in a research report on Wednesday, April 8th. Wells Fargo & Company cut their price objective on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. William Blair initiated coverage on shares of Cencora in a report on Tuesday, April 28th. They set a “market perform” rating for the company. Bank of America upped their target price on shares of Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Finally, Barclays cut their price target on Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 10th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $367.75.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.